Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2019 3
2020 7
2021 9
2022 11
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Extreme Hypofractionation with SBRT in Localized Prostate Cancer.
Gómez-Aparicio MA, Valero J, Caballero B, García R, Hernando-Requejo O, Montero Á, Gómez-Iturriaga A, Zilli T, Ost P, López-Campos F, Couñago F. Gómez-Aparicio MA, et al. Among authors: lopez campos f. Curr Oncol. 2021 Aug 3;28(4):2933-2949. doi: 10.3390/curroncol28040257. Curr Oncol. 2021. PMID: 34436023 Free PMC article. Review.
Watch and wait approach in rectal cancer: Current controversies and future directions.
López-Campos F, Martín-Martín M, Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R, López-Durán S, Domínguez-Rullán J, Ferreiro R, Riquelme-Oliveira A, Hervás-Morón A, Couñago F. López-Campos F, et al. World J Gastroenterol. 2020 Aug 7;26(29):4218-4239. doi: 10.3748/wjg.v26.i29.4218. World J Gastroenterol. 2020. PMID: 32848330 Free PMC article. Review.
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli T, Dirix P, Heikkilä R, Liefhooghe N, Siva S, Gomez-Iturriaga A, Everaerts W, Otte F, Shelan M, Mercier C, Achard V, Thon K, Stellamans K, Moon D, Conde-Moreno A, Papachristofilou A, Scorsetti M, Gückenberger M, Ameye F, Zapatero A, Van De Voorde L, López Campos F, Couñago F, Jaccard M, Spiessens A, Semac I, Vanhoutte F, Goetghebeur E, Reynders D, Ost P. Zilli T, et al. Among authors: lopez campos f. Eur Urol Focus. 2021 Mar;7(2):241-244. doi: 10.1016/j.euf.2020.12.010. Epub 2020 Dec 29. Eur Urol Focus. 2021. PMID: 33386290 Free article. Clinical Trial.
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
Arcos MBL, López-Campos F, Valcarcel ML, Rubio MG, de Manzanos IVF, Duque-Santana V, Aparicio MG, Martin JZ, Kishan AU, Achard V, Siva S, Couñago F. Arcos MBL, et al. Among authors: lopez campos f. Clin Genitourin Cancer. 2023 Jun;21(3):e93-e103. doi: 10.1016/j.clgc.2022.10.015. Epub 2022 Nov 11. Clin Genitourin Cancer. 2023. PMID: 36456467 Review.
Nanoparticles applied to cancer immunoregulation.
Lopez-Campos F, Candini D, Carrasco E, Berenguer Francés MA. Lopez-Campos F, et al. Rep Pract Oncol Radiother. 2019 Jan-Feb;24(1):47-55. doi: 10.1016/j.rpor.2018.10.001. Epub 2018 Nov 2. Rep Pract Oncol Radiother. 2019. PMID: 30425606 Free PMC article. Review.
Novel Approaches in the Systemic Management of High-Risk Prostate Cancer.
Gómez-Aparicio MA, López-Campos F, Lozano AJ, Maldonado X, Caballero B, Zafra J, Suarez V, Moreno E, Arcangeli S, Scorsetti M, Couñago F. Gómez-Aparicio MA, et al. Among authors: lopez campos f. Clin Genitourin Cancer. 2023 Dec;21(6):e485-e494. doi: 10.1016/j.clgc.2023.06.001. Epub 2023 Jun 18. Clin Genitourin Cancer. 2023. PMID: 37453915 Review.
Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review.
Sellés EG, Pieretti DG, Higuero PP, Del Portillo EG, Macías VM, Domínguez MM, Mateos RF, Campos FL, Díaz-Gavela AA, Ferraris G, Couñago F. Sellés EG, et al. Among authors: campos fl. Future Oncol. 2023 Aug;19(25):1753-1768. doi: 10.2217/fon-2023-0481. Epub 2023 Aug 31. Future Oncol. 2023. PMID: 37650764 Review.
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.
Lozano R, Castro E, Lopez-Campos F, Thorne H, Ramirez-Backhaus M, Aragon IM, Cendón-Florez Y, Gutierrez-Pecharroman A, Salles DC, Romero-Laorden N, Lorente D, González-Peramato P, Calatrava A, Alonso C, Anido U, Arévalo-Lobera S, Balmaña J, Chirivella I, Juan-Fita MJ, Llort G, Y Cajal TR, Almagro E, Alameda D, López-Casas PP, Herrera B, Mateo J, Pritchard CC, Antonarakis ES, Lotan TL, Rubio-Briones J, Sandhu S, Olmos D. Lozano R, et al. Among authors: lopez campos f. Eur J Cancer. 2023 May;185:105-118. doi: 10.1016/j.ejca.2023.02.022. Epub 2023 Mar 5. Eur J Cancer. 2023. PMID: 36972661
Immune mechanisms mediating abscopal effects in radioimmunotherapy.
Rodriguez-Ruiz ME, Rodriguez I, Leaman O, López-Campos F, Montero A, Conde AJ, Aristu JJ, Lara P, Calvo FM, Melero I. Rodriguez-Ruiz ME, et al. Among authors: lopez campos f. Pharmacol Ther. 2019 Apr;196:195-203. doi: 10.1016/j.pharmthera.2018.12.002. Epub 2018 Dec 5. Pharmacol Ther. 2019. PMID: 30529041 Review.
45 results